Tuesday, April 30, 2024 9:00 AM to 4:05 PM
Wilentz Shareholder Michael F. Schaff, co-chair of the Corporate, Health, and Cannabis law practice groups, Past Co-Chair of the NJSBA Cannabis Law Special Committee, and Past Chair and current Executive Committee Member of the NJSBA Health Law Section, will co-moderate the program entitled “Latest Developments in Cannabis and Psychedelics Law” presented by NJICLE and the NJSBA Cannabis Law Special Committee. The program will provide an overview of cannabis law and changes since New Jersey passed laws and regulations governing the recreational use of cannabis. The program will also have segments on ethics, dispensary operations and finance planning, monetizing your client’s innovations on a national scale, a hemp update, a litigation update and finally, the newest topic in regulated substances law – psychedelics.
The program agenda includes:
- New Jersey cannabis regulations two (and a half) years in: The sticky and the icky
- Ethics in cannabis law
- Dispensary operations and finance planning
- Monetizing your client’s innovations on a national scale
- Hemp update
- Litigation update
- Up Next: Psychedelics
- Legislative updates and commentary
For more information and to register, please visit the event page.
This program has been approved by the Board on Continuing Legal Education of the Supreme Court of New Jersey for 6.9 hours of total CLE credit, including 0.7 in Ethics (Full Credits Available: NJ Ethics: 0.7, NJ General: 6.2).
*Cannabis Law Disclaimer: Per federal law, under the Controlled Substances Act, marijuana is categorized as a Schedule I controlled substance. Possession, use, distribution, and/or sale of cannabis is a Federal crime and is subject to related Federal policy, regardless of any state law that may authorize certain marijuana activity. Compliance with state marijuana law does not equal compliance with federal law. Legal advice provided by Wilentz, Goldman & Spitzer, P.A. is designed to counsel clients regarding the validity, scope, meaning, and application of existing and/or proposed cannabis law. Wilentz, Goldman & Spitzer, P.A. will not provide guidance or assistance in circumventing or violating Federal or state cannabis law or policy, and any advice provided by Wilentz, Goldman & Spitzer, P.A. should not be construed as such.